| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |